A complete biocompatibility evaluation profile is an essential step in gaining regulatory approval of your new medical device. What happens when you find out that the device your company is riding on fails a biocompatibility endpoint evaluation? How could this happen? What are you to do next? Not every failure is real. Not every failure is relevant. Not every failure is the end of the line. Every failure, however, must be addressed and how you address it could be worse than the failure itself. (Sponsored by Toxikon)
In a live interview, Insulet’s president and CEO, Shacey Petrovic, will share lessons learned from her career in medtech and provide insights about Insulet’s tubeless Omnipod Insulin Management System.
As our lives have become centered around wearable and wireless technology, the medtech industry has followed suit, adapting devices to conform with the digital era. Panelists will share how they’ve developed technologies that can thrive in a connected, user-centered world.
To get a product to the patient, medtech companies first have to navigate a tangled web comprised of design processes, testing requirements, regulations and reimbursement. Panelists will share their own experiences of bringing an idea through the device development process and ultimately to the market.
Recent advances in medical technology have radically improved the ability to diagnose disorders, overcome physical handicaps, and provide new paradigms for disability access. However, significant needs remain in neurology and physiotherapy, as well as for expanded access to prosthetics and other means of human machine control. CTRL-labs has developed a noninvasive neural interface supported by machine learning that will empower medical partners to explore unprecedented clinical solutions in their field. In this discussion, Director of Clinical & Research Partnership Dan Wetmore outlines the future of medical devices and the need to embrace nascent technologies that can revolutionize patient care.
Engineers and product development pros from local medical device companies will share the unique challenges and opportunities that arise in building devices for cancer detection and treatment. Get an inside look into the companies that are shaping the way cancer will be diagnosed and treated in the years to come.
To get a product to the market, medical device companies need to employ strategies that are realistic based upon the needs, resources and infrastructure of the marketplace. In this discussion, panelists will share their own experiences navigating healthcare systems outside of the U.S.